PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation

Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E435-42. doi: 10.1152/ajpendo.00143.2002. Epub 2002 Oct 8.

Abstract

Increases in extracellular calcium concentration ([Ca(2+)](o)) stimulate from normal and malignant cells secretion of parathroid hormone-related protein (PTHrP), a major mediator of humoral hypercalcemia of malignancy. Because the calcium-sensing receptor (CaR) is a determinant of calcium-regulated hormone secretion, we examined whether HEK cells stably transfected with human CaR secreted PTHrP in response to CaR stimulation. Increases in [Ca(2+)](o) or neomycin and Gd(3+) all substantially increased PTHrP secretion in CaR-HEK cells but had no effect on nontransfected cells. CaR activation likewise increased PTHrP transcripts. PD-098059 and U-0126, inhibitors of the mitogen-activated protein kinase kinase MEK1/2, abolished CaR-stimulated secretion but had no effect on basal secretion. An inhibitor of p38 MAP kinase, SB-203580, also attenuated CaR-stimulated secretion. Western analysis revealed that CaR activation caused a robust increase in MEK1/2 and p38 MAP kinase phosphorylation. A Src family kinase inhibitor, PP2, blocked both basal and CaR-stimulated secretion. We conclude that CaR specifically mediates the effect of increasing [Ca(2+)](o) on PTHrP synthesis and secretion and that activated MEK1/2 and p38 MAP kinases are determinants of the CaR's stimulation of PTHrP secretion.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Aniline Compounds / pharmacology
  • Anisomycin / pharmacology
  • Calcium / agonists
  • Calcium / pharmacology
  • Cations / pharmacology
  • Cell Line
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Kidney / cytology
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism*
  • Parathyroid Hormone-Related Protein
  • Peptide Hormones / genetics
  • Peptide Hormones / metabolism*
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism
  • Protein Synthesis Inhibitors / pharmacology
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Receptors, Calcium-Sensing
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*
  • Transcription, Genetic / drug effects
  • Transfection
  • p38 Mitogen-Activated Protein Kinases
  • src-Family Kinases / antagonists & inhibitors

Substances

  • Aniline Compounds
  • Cations
  • Enzyme Inhibitors
  • NPS R-467
  • PTHLH protein, human
  • Parathyroid Hormone-Related Protein
  • Peptide Hormones
  • Protein Synthesis Inhibitors
  • Receptors, Calcium-Sensing
  • Receptors, Cell Surface
  • Adenosine Diphosphate
  • Anisomycin
  • MAP2K2 protein, human
  • Protein-Tyrosine Kinases
  • src-Family Kinases
  • Protein Serine-Threonine Kinases
  • Protein Kinase C
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • MAP2K1 protein, human
  • Mitogen-Activated Protein Kinase Kinases
  • Calcium